Press "Enter" to skip to content

FDA authorizes first test to aid in newborn screening for Duchenne Muscular Dystrophy

Today, the U.S. Food and Drug Administration authorized marketing of the first test to aid in newborn screening for Duchenne Muscular Dystrophy (DMD), a rare genetic disorder that causes progressive muscle deterioration and weakness.

Original source: http://www.fda.gov/news-events/press-announcements/fda-authorizes-first-test-aid-newborn-screening-duchenne-muscular-dystrophy

Also Read:   Coronavirus (COVID-19) Update: Daily Roundup April 23, 2020